Latest News from: St. Jude Children's Research Hospital

Filters close
Newswise: Children genetically prone to cancer benefit from early standardized surveillance
Released: 20-Jun-2024 12:05 PM EDT
Children genetically prone to cancer benefit from early standardized surveillance
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital found that, with early screening, they could detect new cancers in pediatric patients with an underlying genetic predisposition at their most treatable stages.

Newswise: St. Jude scientists solve decades long mystery of NLRC5 sensor function in cell death
Released: 14-Jun-2024 3:40 PM EDT
St. Jude scientists solve decades long mystery of NLRC5 sensor function in cell death
St. Jude Children's Research Hospital

Learn about immunology research from the St. Jude laboratory of Thirumala-Devi Kanneganti, PhD, that revealed the function of the NLRC5 innate immune sensor. 

   
Newswise: Novel insights into fluorescent ‘dark states’ illuminate ways forward for improved imaging
Released: 14-Jun-2024 12:05 PM EDT
Novel insights into fluorescent ‘dark states’ illuminate ways forward for improved imaging
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists address decades-long problem in the field of single-molecule fluorescence resonance energy transfer, paving the way for more accurate experiments.

Newswise: Age is just a number: Immune cell ‘epigenetic clock’ ticks independently of organism lifespan 
Released: 12-Jun-2024 10:50 AM EDT
Age is just a number: Immune cell ‘epigenetic clock’ ticks independently of organism lifespan 
St. Jude Children's Research Hospital

See how St. Jude researchers use epigenetic clock, DNA methylation and mouse model to demonstrate that T cell proliferation can stretch past organism lifespan and acuta lymphoblastic leukemia T cells appear hundreds of years old.

Newswise: Cell-targeting technology allows researchers to isolate neuronal subpopulations and link them to behavioral states
Released: 28-May-2024 12:05 PM EDT
Cell-targeting technology allows researchers to isolate neuronal subpopulations and link them to behavioral states
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital designed an intersectional technique for precisely targeting subpopulations of cells and parsing out specific functions.

   
Newswise: Repurposed protease controls important signaling molecule-activating protein
Released: 22-May-2024 11:05 AM EDT
Repurposed protease controls important signaling molecule-activating protein
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital reveal the role of iRhom2’s defunct protein-cleaving domain in lifecycle of ADAM17, a key signaling molecule-activating protein.

Newswise: Novel inhibitor insights offer pathway to preventing PXR-associated drug resistance
Released: 14-May-2024 4:05 PM EDT
Novel inhibitor insights offer pathway to preventing PXR-associated drug resistance
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital uncovered a route to blocking activity of protein notorious for eliminating drugs, offering a potential boon to cancer therapy.

Newswise: Hongbo Chi, PhD named 2023 AAAS Fellow
Released: 29-Apr-2024 1:05 PM EDT
Hongbo Chi, PhD named 2023 AAAS Fellow
St. Jude Children's Research Hospital

Hongbo Chi, PhD, a faculty member and the Robert G. Webster Endowed Chair in Immunology at St. Jude Children’s Research Hospital, has been recognized as a fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science Family of Journals.

Newswise: Targeting specific protein regions offers a new treatment approach in medulloblastoma
Released: 25-Apr-2024 2:05 PM EDT
Targeting specific protein regions offers a new treatment approach in medulloblastoma
St. Jude Children's Research Hospital

Explore how research targeting EP300/CBP protein in Group 3 medulloblastoma may advance targeted pediatric brain tumor treatments by inhibiting bromodomains.

Released: 23-Apr-2024 4:05 PM EDT
Genetics predict type 2 diabetes risk and disparities in childhood cancer survivors
St. Jude Children's Research Hospital

Learn how ancestry changes genetic risk variants’ impact on type 2 diabetes in childhood cancer survivors & alkylating agent exposure magnifies diabetes risk.

Newswise: Metabolic health before vaccination determines effectiveness of anti-flu response
Released: 18-Apr-2024 11:05 AM EDT
Metabolic health before vaccination determines effectiveness of anti-flu response
St. Jude Children's Research Hospital

Poor metabolic health or dysfunction, not obesity, leads to poor anti-influenza immune responses. Learn about the new St. Jude influenza vaccination research.

Newswise: Andrew Smith, MD, PhD, named chair of Diagnostic Imaging at St. Jude Children’s Research Hospital
Released: 15-Apr-2024 11:00 AM EDT
Andrew Smith, MD, PhD, named chair of Diagnostic Imaging at St. Jude Children’s Research Hospital
St. Jude Children's Research Hospital

Smith is a nationally recognized academic radiologist with expertise in body and oncologic imaging, clinical trials and imaging research and the application of artificial intelligence (AI) in imaging and medicine.

Newswise: New drug prevents flu-related inflammation and lung damage
Released: 10-Apr-2024 11:05 AM EDT
New drug prevents flu-related inflammation and lung damage
St. Jude Children's Research Hospital

Findings show a newly created drug can prevent runaway inflammation while still allowing the immune system to handle the virus, even when given late into infection.

Newswise: St. Jude survivorship portal brings researchers ‘one-click’ away from discovery
Released: 9-Apr-2024 3:05 PM EDT
St. Jude survivorship portal brings researchers ‘one-click’ away from discovery
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital today announces the survivorship portal, part of the St. Jude Cloud ecosystem, for unparalleled data analysis and visualization.

   
Newswise: Targeting vulnerability in B-cell development leads to novel drug combination for leukemia
Released: 8-Apr-2024 2:45 PM EDT
Targeting vulnerability in B-cell development leads to novel drug combination for leukemia
St. Jude Children's Research Hospital

Recent work by St. Jude Children’s Research Hospital scientists discovered which tumor cells resist treatment and why. By characterizing B-cells’ developmental stages, they designed and tested a drug combination to effectively treat resistant B-cell leukemia.

Newswise: Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes
Released: 28-Mar-2024 12:05 PM EDT
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may point toward favorable outcomes
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists studying bilateral Wilms tumor found that chemotherapy resistance correlates with tumors favorable to surgery, reducing the need for additional therapy.

Newswise: Researchers turn back the clock on cancer cells to offer new treatment paradigm
Released: 27-Mar-2024 12:05 PM EDT
Researchers turn back the clock on cancer cells to offer new treatment paradigm
St. Jude Children's Research Hospital

St. Jude Children’s Research Hospital scientists reversed an aggressive cancer, reverting malignant cells towards a more normal state.

Newswise: Scientists Find Core Regulatory Circuit Controlling Identity of Aggressive Leukemia
Released: 21-Mar-2024 1:05 PM EDT
Scientists Find Core Regulatory Circuit Controlling Identity of Aggressive Leukemia
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital and Dana-Farber Cancer Institute found a small set of proteins that maintain anaplastic large cell lymphoma (ALCL) identity, representing potential future therapeutic targets.

Newswise: Change in Mycn-Driven Cell State Opens Therapeutic Window in High-Risk Neuroblastoma
Released: 19-Mar-2024 11:05 AM EDT
Change in Mycn-Driven Cell State Opens Therapeutic Window in High-Risk Neuroblastoma
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital showed that the MYCN protein promotes a switch in the cellular state within the tumor microenvironment, with slow-growing mesenchymal cells swapping to the more dangerous and faster-growing adrenergic state.

   
Newswise: Immunotherapy Targeting Cancer Fusion Protein May Hold Key to Treating Rare Liver Cancer
Released: 19-Mar-2024 11:05 AM EDT
Immunotherapy Targeting Cancer Fusion Protein May Hold Key to Treating Rare Liver Cancer
St. Jude Children's Research Hospital

Researchers from St. Jude Children’s Research Hospital and The University of Tennessee Health Sciences Center discovered two T-cell receptors in a single patient that recognizes the fusion and can guide T cells to kill all tumor cells carrying the hybrid protein in a mouse model.



close
0.13121